Users online: 1892    [ij] [ij] [ij] 
Email id

Research Journal of Pharmacy and Technology
Year : 2016, Volume : 9, Issue : 10
First page : ( 1815) Last page : ( 1818)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2016.00369.3

Efficacy of fifth generation cephalosporins against methicillin-resistant Staphylococcus aureus-A review

Selvan Subashree Rathi1,*, Dr. Ganapathy Dhanraj2

1CRRI, Saveetha Dental College and Hospitals, Chennai

2HOD, Dept. of Prosthodontics, Saveetha Dental College, Chennai

*Corresponding Author E-mail: subashree.rathi@gmail.com

Online published on 2 March, 2017.


In recent decades, microbial resistance has reached to an incredibly alarming levels, leading to the development of more potent antimicrobial agents. MRSA (Methicillin-Resistant Staphylococcus aureus) in particular, has become the leading cause of skin and soft tissue infections. Severe or potentially life-threatening MRSA infections occur most frequently among patients in contact with health care settings, according to the Centers for Disease Control and Prevention. Novel fifth generation cephalosporins, including ceftaroline fosamate and ceftobiprole medocaril has shown their efficacy in the treatment of acute bacterial skin and soft tissue infections and community acquired bacterial pneumonia. Till date, ceftaroline has provided a safe use with minimal side effects and exhibits a low potential to induce resistance, though further clinical data in the long run is required.



Ceftaroline, cephalosporin, antibiotic, ceftobiprole, MRSA.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
576,152,206 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.